Cardiovascular implications of idiopathic pulmonary fibrosis: A way forward together?
- 6 May 2020
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 226, 69-74
- https://doi.org/10.1016/j.ahj.2020.04.027
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart diseaseFibrogenesis & Tissue Repair, 2012
- Angiotensin signalling in pulmonary fibrosisThe International Journal of Biochemistry & Cell Biology, 2012
- Delayed Access and Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Clinical review: Idiopathic pulmonary fibrosis acute exacerbations - unravelling Ariadne's threadCritical Care, 2010
- JunD and HIF‐1α mediate transcriptional activation of angiotensinogen by TGF‐β1 in human lung fibroblastsThe FASEB Journal, 2009
- Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart FailureJournal of the American College of Cardiology, 2006
- Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmiaImmunology, 2006
- Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repairCardiovascular Pathology, 2005
- Both Platelet-Derived Growth Factor Receptor (PDGFR)-α and PDGFR-β Promote Murine Fibroblast Cell MigrationBiochemical and Biophysical Research Communications, 2001